Home / Inspections / 1264839

FDA Inspection 1264839 — American Blood Bank Corp.

American Blood Bank Corp. — FEI 3007651216

The FDA completed an inspection of American Blood Bank Corp. on March 19, 2025 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 19, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Miami, FL (United States)

Facility

Other inspections at this facility

  • 1173726 (NAI Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1098924 (VAI Wed Aug 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 980945 (VAI Thu May 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 894213 (VAI Fri Sep 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 799803 (NAI Wed Sep 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources